In last trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 6.18 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price level of $0.11 trading at $0.0 or -0.72% at ring of the bell on the day assigns it a market valuation of $4.09M. That closing price of CNSP’s stock is at a discount of -124900.0% from its 52-week high price of $137.50 and is indicating a premium of 9.09% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 72.14 million shares which gives us an average trading volume of 13.83 million if we extend that period to 3-months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Upright in the red during last session for losing -0.72%, in the last five days CNSP remained trading in the red while hitting it’s week-highest on Friday, 11/01/24 when the stock touched $0.11 price level, adding 17.29% to its value on the day. Cns Pharmaceuticals Inc’s shares saw a change of -99.83% in year-to-date performance and have moved -9.47% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of -13.59% in past 30-days. Number of shares sold short was 1.11 million shares which calculate 0.98 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have assigned a consensus price target of 0.5 to the stock, which implies a rise of 78.0% to its current value. Analysts have been projecting 0.5 as a low price target for the stock while placing it at a high target of 0.5. It follows that stock’s current price would drop -354.55% in reaching the projected high whereas dropping to the targeted low would mean a loss of -354.55% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.98% during past 5 years.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders are in possession of 1.21% of company’s total shares while institution are holding 0.29 percent of that, with stock having share float percentage of 0.29%. Investors also watch the number of corporate investors in a company very closely, which is 0.29% institutions for Cns Pharmaceuticals Inc that are currently holding shares of the company.
